Market Scenario

Global Prosthetic Heart Valve market is expected to reach USD 8,392 Bn by 2026 at a CAGR of 9.5 % during the forecast period.

The Global Prosthetic Heart Valve market is segmented based on type, end user region.
By Product type - transcatheter valve, tissue heart valves, mechanical valve.
By End User – Hospitals, Ambulatory Surgical Centers. By region - North America & South America, Europe, Asia-Pacific and, Middle East & Africa
The prosthetic heart valve is a medical device that implants in the heart disease patient who is suffering from heart failure. The mechanism of this device is that heart valve consists of orifices, which are provided blood flow.

Major Market Drivers:
• Technology advancement.
• Rising cases of heart valve disorder.
• Increasing healthcare expenditure.
• Rising number of heart diseases.
• Increasing awareness about the diagnosis and availability of treatment for heart valve disorder.
• Strict government regulation.

Restraint:
• Lack of skilled professional.
• High cost of development and reimbursement

Global Prosthetic Heart Valve Market

Strategic Developments in the Global Prosthetic Heart Valve Market:
In 2018, Abbott was getting FDA approval for new product Masters HP. The mechanical heart valve is the world smallest product and it is used in aortic valve replacement.
In 2017, Edwards Lifesciences, LLC, got FDA approval for SAPIEN 3 Transcatheter Heart Valve. This product is basically used in heart valve replacement.

Type Insights:
Transcatheter valve and tissue heart valves segment are expected to reveal exponential CAGR throughout the forecast period due to innovative product launches, and rising cases of heart valve disorder and increasing healthcare expenditure across the globe.

The North American region is playing the principal role in the global prosthetic heart valve market due to the presence of several leading players. Though, Asia-Pacific will be the second major market in the proximate future. The presence of innovative medical advanced technology, rising cases of heart valve disorder, increasing healthcare expenditure, the rising number of heart diseases in the region.
Scope of the Global Prosthetic Heart Valve Market Report

Global Prosthetic Heart Valve Market, by Type

• Transcatheter Valve
• Tissue Heart Valves
• Mechanical Valve
Global Prosthetic Heart Valve Market, by End Users

• Hospitals
• Ambulatory Surgery Centres
Global Prosthetic Heart Valve Market, By Region

• North America
• Europe
• Asia Pacific
• Middle East
• Africa
Global Prosthetic Heart Valve Market Key Players

• Abbott, Medtronic
• Medical Technology Est.
• Boston Scientific Corporation
• Micro Interventional Devices, Inc.
• Medical Circle
• Edwards Lifesciences Corporation
• LivaNova PLC.
• JenaValve Technology, Inc.
• Cryolife, Inc.
• TTK HealthCare
• JenaValve Technology, Inc.
• LivaNova PLC
• Lepu Medical Technology (Beijing) Co., Ltd...
• Braile Biomédica, SYMETIS
• Medtronic
• Commonwealth Edison Company
• Labcor Laboratórios Ltda.
• JenaValve
• LEPU MEDICAL TECHNOLOGY
• Braile Biomédica
• Colibri Heart Valve
• Cardiac Dimensions Inc
• Cardiosolutions, Inc.
• Leman Cardiovascular
• Medtentia AB
• MitralSolutions, Inc
• On-X Life Technologies, Inc
• Sadra Medical, Inc.
• Sorin S.p.A.
• St. Jude Medical, Inc
• ValveXchange, Inc

Reasons to Purchase this Report:

• Current and future of global deep global prosthetic heart valve market, the outlook in the developed and emerging markets.
• The segment that is predictable to lead the market as well as the segment which holds highest CAGR in the forecast period.
• Regions/countries that are expected to witness the fastest growth rates during the forecast period.
• The latest innovative developments, market shares, and strategies that are employed by the major market players.